It is likely that in the present study, α1-AT concentrations were similar between the clinical stages of patients with BC because all participants were receiving cytotoxic chemotherapy prior to the time the samples were collected, and it is known that damaged liver disease is one of the most common adverse effects of cytotoxic treatment [60,61]. Here, SERPINA1 is linked to liver disorder.